Back
Repligen Stock Predictions
Sponsored
RGEN
Sponsored
My #1 Coin is...
All the details are on the next page.
Buy
62
RGEN
Repligen
Last Price:
167.12
Seasonality Move:
5.57%
7 Day Trial
ALL ACCESS PASS
$
7
Stock Market Legend Shares Biggest Prediction Ever:
Click Here to SeeRepligen Stock Forecast
- Over the next 52 weeks, Repligen has on average historically risen by 18.8% based on the past 37 years of stock performance.
- Repligen has risen higher in 21 of those 37 years over the subsequent 52-week period, corresponding to a historical accuracy of 56.76%
-
Is Repligen Stock Undervalued?
The current Repligen [RGEN] share price is $167.05. The Score for RGEN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal. - RGEN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Repligen Stock Go Up Next Year?
- Over the next 52 weeks, Repligen has on average historically risen by 18.8% based on the past 37 years of stock performance.
Repligen Stock Rating
Buy
62
Repligen (RGEN)
is a Buy
Is Repligen overpriced?
- Repligen has risen higher in 21 of those 37 years over the subsequent 52-week period, corresponding to a historical accuracy of 56.76%
Repligen Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
repligen.com
52-Week Data
52-Week High:
211.13
52-Week Low:
110.45
Prediction Charts
Market Cap:
9.33B
Price in USD:
167.05
Volume:
454.92K
Beta:
0.99
Technical Analysis
SMA50:
181.06
SMA100:
183.34
SMA200:
170.86
52-Wk Change:
2.21%
Stock Predictions
-
Is Repligen stock public?
Yes, Repligen is a publicly traded company. -
What is the Repligen stock quote today?
The Repligen stock price is 167.05 USD today. -
How to buy Repligen stock online?
You can buy Repligen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-16 | 165.96 | 164.25 | 166.21 | 160.91 |
Apr-17 | 165.22 | 160.91 | 169.21 | 160.16 |
Apr-18 | 154.59 | 157.05 | 159.35 | 152.19 |
Apr-19 | 157.63 | 157.14 | 159.41 | 156.33 |
Apr-22 | 158.03 | 157.48 | 159.70 | 154.87 |
Apr-23 | 166.49 | 171.28 | 174.30 | 165.44 |
Apr-24 | 169.82 | 167.86 | 173.48 | 165.91 |
Apr-25 | 166.21 | 165.66 | 168.11 | 163.23 |
Apr-26 | 165.66 | 166.58 | 168.46 | 165.05 |
Apr-29 | 167.91 | 166.14 | 168.96 | 163.22 |
Apr-30 | 164.54 | 164.46 | 168.28 | 164.01 |
May-1 | 159.00 | 158.20 | 164.15 | 151.82 |
May-2 | 160.61 | 166.31 | 166.71 | 155.48 |
May-3 | 170.10 | 167.05 | 172.00 | 166.43 |
Repligen Earnings
Repligen Earnings Report: Per Share Repligen Earnings Q1 Q2 Q3 and Q4 last year and next year.
Repligen Forecast Revenue Growth
Repligen Stock Analysis: Historical quarterly revenues per share for Repligen and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.22 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.28 per share, and an increase next year of $0.56 per share.
* Repligen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.